Fin Trust Capital Advisors, LLC Ensysce Biosciences, Inc. Transaction History

Fin Trust Capital Advisors, LLC

  • $577 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022
SELL
$100.8 - $345.6 $35,280 - $120,960
-350 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$300.0 - $1228.8 $105,000 - $430,080
350 New
350 $2,000

Others Institutions Holding ENSC

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0
View Full List

About Ensysce Biosciences, Inc.

ENSC Quotes by TradingView
  • Ticker ENSC
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,918,900
  • Market Cap $1.25M
  • Description
  • Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...
More about ENSC
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email